Related references
Note: Only part of the references are listed.Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition
Allison J. Greaney et al.
CELL HOST & MICROBE (2021)
Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19 A Randomized Clinical Trial
Robert L. Gottlieb et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Extremely potent human monoclonal antibodies from COVID-19 convalescent patients
Emanuele Andreano et al.
CELL (2021)
Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence
Ester C. Sabino et al.
LANCET (2021)
mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants
Zijun Wang et al.
NATURE (2021)
SARS-CoV-2 escaped natural immunity, raising questions about vaccines and therapies
Emanuele Andreano et al.
NATURE MEDICINE (2021)
Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2
Renhong Yan et al.
SCIENCE (2020)
Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2
Qihui Wang et al.
CELL (2020)
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
Alexandra C. Walls et al.
CELL (2020)
Evaluation of SARS-CoV-2 neutralizing antibodies using a CPE-based colorimetric live virus micro-neutralization assay in human serum samples
Alessandro Manenti et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses
Shibo Jiang et al.
TRENDS IN IMMUNOLOGY (2020)
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
Jun Lan et al.
NATURE (2020)
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
Pedro M. Folegatti et al.
LANCET (2020)
Coronavirus RNA Proofreading: Molecular Basis and Therapeutic Targeting
Fran Robson et al.
MOLECULAR CELL (2020)
SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2
Thomas Mandel Clausen et al.
CELL (2020)
Potently neutralizing and protective human antibodies against SARS-CoV-2
Seth J. Zost et al.
NATURE (2020)
An mRNA Vaccine against SARS-CoV-2-Preliminary Report
L. A. Jackson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2
Xiangyang Chi et al.
SCIENCE (2020)
Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies
Alina Baum et al.
SCIENCE (2020)
Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model
Thomas F. Rogers et al.
SCIENCE (2020)
Structure-based design of prefusion-stabilized SARS-CoV-2 spikes
Ching-Lin Hsieh et al.
SCIENCE (2020)
Structures and distributions of SARS-CoV-2 spike proteins on intact virions
Zunlong Ke et al.
NATURE (2020)
Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate
Sandhya Bangaru et al.
SCIENCE (2020)
Structural Basis of SARS-CoV-2 and SARS-CoV Antibody Interactions
Edem Gavor et al.
TRENDS IN IMMUNOLOGY (2020)
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
Bina Choi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Genome evolution of SARS-CoV-2 and its virological characteristics
So Nakagawa et al.
INFLAMMATION AND REGENERATION (2020)
A systematic review of SARS-CoV-2 vaccine candidates
Yetian Dong et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Human Influenza A Virus Hemagglutinin Glycan Evolution Follows a Temporal Pattern to a Glycan Limit
Meghan O. Altman et al.
MBIO (2019)
cisTEM, user friendly software for single-particle image processing
Timothy Grant et al.
ELIFE (2018)
Safety and antiviral activity of combination HIV-1 broadly neutralizing antibodies in viremic individuals
Yotam Bar-On et al.
NATURE MEDICINE (2018)
GISAID: Global initiative on sharing all influenza data - from vision to reality
Yuelong Shu et al.
EUROSURVEILLANCE (2017)
cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination
Ali Punjani et al.
NATURE METHODS (2017)
Data, disease and diplomacy: GISAID's innovative contribution to global health
Stefan Elbe et al.
GLOBAL CHALLENGES (2017)
N463 Glycosylation Site on V5 Loop of a Mutant gp120 Regulates the Sensitivity of HIV-1 to Neutralizing Monoclonal Antibodies VRC01/03
Wenbo Wang et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2015)
A systematic study of the N-glycosylation sites of HIV-1 envelope protein on infectivity and antibody-mediated neutralization
Wenbo Wang et al.
RETROVIROLOGY (2013)
Tracking global patterns of N-linked glycosylation site variation in highly variable viral glycoproteins:: HIV, SIV, and HCV envelopes and influenza hemagglutinin
M Zhang et al.
GLYCOBIOLOGY (2004)
Share Paper
